title: Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma.
abstract: Natural killer cells (NK) as components of the innate immunity substantially contribute to anti-tumor immune responses, NK cell subpopulations can be defined on the basis of the relative expression of CD16 and CD56 markers. Earlier research demonstrated a dramatic reduction in the frequency of peripheral blood CD56dimCD16+ NK subsets in hepatocellular carcinoma (HCC) patients compared with healthy subjects. We aim to assess the relative and absolute counts of natural killer cells subsets in hepatitis C-related HCC among Egyptian patients. Flowcytometric analysis of peripheral blood NK subsets was performed for HCV with HCC patients (n=20) and HCV without HCC patients (n=14) as compared to healthy control subjects (n=152). We found that HCC patients displayed a marked reduction in the relative frequency of peripheral CD56im subsets compared with healthy subjects. Moreover, there was a significant reduction in the absolute counts of CD56dim16+, CD56dim16- and CD56bright. In conclusion, this study demonstrated that the absolute counts of dim and bright NK cell subsets were decreased in different proportions in patients with HCV-related HCC that refers to a possible role for these cells, particularly CD 56 bright cells, in the immune response to HCC. This might aid in developing new therapeutic strategies targeting both NK subsets for HCC.
authors: Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Egypt.
authors: Amal
authors: A
authors: Fathy
authors: Mohamed Mohy
authors: MM
authors: Eldin
authors: Lobna
authors: L
authors: Metwally
authors: Mohamed
authors: M
authors: Eida
authors: Marwa
authors: M
authors: Abdel-Rehim
mesh_terms: D019002:CD56 Antigen / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology; D002452:Cell Count; D004534:Egypt; D005260:Female; D016174:Hepacivirus / Q000276:immunology* / Q000472:pathogenicity; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007113:Immunity, Innate; D016130:Immunophenotyping; D007694:Killer Cells, Natural / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008113:Liver Neoplasms / Q000150:complications / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D017452:Receptors, IgG / Q000378:metabolism
chemical_list: D019002:CD56 Antigen; D017452:Receptors, IgG